Freiman Paul E. Insider Trades

Insider Trading History

Track insider trading activity for Freiman Paul E.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 30,000 shares
$4.93
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $1.26k 858 shares
Last Trade
Jun 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.4k 858 shares
$23.80
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $2.52k 1,716 shares
Last Trade
May 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30k 858 shares
$34.99
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $0 0 shares
Last Trade
May 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$30k 858 shares
$34.99
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 21, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.31M 30,000 shares
$243.78
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.73M 30,000 shares
$224.18
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
May 21, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.1M 30,000 shares
$838.27
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $29.4k 20,000 shares
Last Trade
May 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.8M 20,000 shares
$1,090.25
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $29.4k 20,000 shares
Last Trade
May 30, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.37M 20,000 shares
$368.73
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $92.2k 62,697 shares
Last Trade
May 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$53.9M 20,000 shares
$2,695.00
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $98.6k 67,097 shares
Last Trade
Jan 03, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$103M 25,916 shares
$3,971.45
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $60.5k 41,181 shares
Last Trade
Jan 04, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$332M 26,835 shares
$12,372.50
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $527k 358,654 shares
Last Trade
Jan 02, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.9B 121,144 shares
$97,938.94
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $349k 237,510 shares
Last Trade
Jan 02, 2014 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.96B 15,000 shares
$197,531.63
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $327k 222,510 shares
Last Trade
Jan 02, 2013 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.6B 15,000 shares
$173,031.58
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $99.2k 67,510 shares
Last Trade
Jan 03, 2012 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.7B 67,510 shares
$203,656.63
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $66.3k 45,137 shares
Last Trade
Dec 29, 2011 Purchase (In The Money)Reported as In The Money on SEC Form 4.
$5.65B 30,000 shares
$188,344.11
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $44.1k 30,000 shares
Last Trade
Dec 29, 2011 Sale (In The Money)Reported as In The Money on SEC Form 4.
$5.65B 30,000 shares
$188,344.11
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $22.2k 15,137 shares
Last Trade
Sep 12, 2011 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$427M 3,000 shares
$142,406.52
$1.47
Novabay Pharmaceuticals
Novabay Pharmaceuticals NBY
Director
Holding Value $22k 15,000 shares
Last Trade
Jan 03, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.84B 15,000 shares
$255,734.55
$1.47

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up